Association of blood pressure level with nonalcoholic fatty liver disease in nonhypertensive population: Normal is not the new normal

The functional crosstalk between nonalcoholic fatty liver disease (NAFLD) and hypertension has been reported by some literatures; however, in nonhypertensive individuals, there is no article describes the characteristic of NAFLD. In this study, we aimed to determine the strength of the association b...

Full description

Saved in:
Bibliographic Details
Published inMedicine (Baltimore) Vol. 95; no. 29; p. e4293
Main Authors Qian, Lin-Yan, Tu, Jian-Fei, Ding, Ya-Hui, Pang, Jie, Che, Xian-Da, Zou, Hai, Huang, Dong-Sheng
Format Journal Article
LanguageEnglish
Published United States The Authors. Published by Wolters Kluwer Health, Inc. All rights reserved 01.07.2016
Wolters Kluwer Health
Subjects
Online AccessGet full text
ISSN0025-7974
1536-5964
DOI10.1097/MD.0000000000004293

Cover

Abstract The functional crosstalk between nonalcoholic fatty liver disease (NAFLD) and hypertension has been reported by some literatures; however, in nonhypertensive individuals, there is no article describes the characteristic of NAFLD. In this study, we aimed to determine the strength of the association between NAFLD with normal blood pressure (BP) in nonhypertensive individuals. This cross-sectional study was conducted in the sixth Affiliated Hospital of Wenzhou Medical University, from October 2007 to December 2011. In brief, 24,200 subjects were enrolled to participate in the survey. Among those subjects, there were 5305 enrolled subjects, those with filling the diagnostic criteria for NAFLD (21.9%; 4803 males and 502 females). Nonhypertension was identified in 17,403 (71.9%; 8179 males and 9224 females). The PR% of NAFLD for the systolic blood pressure (SBP) in quartiles 1 to 4 was 10.83, 12.55, 20.38, and 19.97. SBP, diastolic blood pressure (DBP), sex, age, glutamic pyruvic transaminase, glutamic oxaloacetic transaminase, fasting plasma glucose, uric acid, triglyceride, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol are closely associated with the risk for NAFLD. SBP (odds ratio [OR]: 1.092, 95% confidence interval [CI]: 1.030-1.158; P < 0.05) and DBP (OR: 1.157, 95%CI: 1.094-1.223; P < 0.05) were found to be independent risk factors for NAFLD. Our analysis indicates that BP is significantly associated with NAFLD in nonhypertensive individuals; SBP and DBP are found to be independent risk factors for NAFLD.
AbstractList The functional crosstalk between nonalcoholic fatty liver disease (NAFLD) and hypertension has been reported by some literatures; however, in nonhypertensive individuals, there is no article describes the characteristic of NAFLD. In this study, we aimed to determine the strength of the association between NAFLD with normal blood pressure (BP) in nonhypertensive individuals. This cross-sectional study was conducted in the sixth Affiliated Hospital of Wenzhou Medical University, from October 2007 to December 2011. In brief, 24,200 subjects were enrolled to participate in the survey. Among those subjects, there were 5305 enrolled subjects, those with filling the diagnostic criteria for NAFLD (21.9%; 4803 males and 502 females). Nonhypertension was identified in 17,403 (71.9%; 8179 males and 9224 females). The PR% of NAFLD for the systolic blood pressure (SBP) in quartiles 1 to 4 was 10.83, 12.55, 20.38, and 19.97. SBP, diastolic blood pressure (DBP), sex, age, glutamic pyruvic transaminase, glutamic oxaloacetic transaminase, fasting plasma glucose, uric acid, triglyceride, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol are closely associated with the risk for NAFLD. SBP (odds ratio [OR]: 1.092, 95% confidence interval [CI]: 1.030-1.158; P < 0.05) and DBP (OR: 1.157, 95%CI: 1.094-1.223; P < 0.05) were found to be independent risk factors for NAFLD. Our analysis indicates that BP is significantly associated with NAFLD in nonhypertensive individuals; SBP and DBP are found to be independent risk factors for NAFLD.
The functional crosstalk between nonalcoholic fatty liver disease (NAFLD) and hypertension has been reported by some literatures; however, in nonhypertensive individuals, there is no article describes the characteristic of NAFLD. In this study, we aimed to determine the strength of the association between NAFLD with normal blood pressure (BP) in nonhypertensive individuals. This cross-sectional study was conducted in the sixth Affiliated Hospital of Wenzhou Medical University, from October 2007 to December 2011. In brief, 24,200 subjects were enrolled to participate in the survey. Among those subjects, there were 5305 enrolled subjects, those with filling the diagnostic criteria for NAFLD (21.9%; 4803 males and 502 females). Nonhypertension was identified in 17,403 (71.9%; 8179 males and 9224 females). The PR% of NAFLD for the systolic blood pressure (SBP) in quartiles 1 to 4 was 10.83, 12.55, 20.38, and 19.97. SBP, diastolic blood pressure (DBP), sex, age, glutamic pyruvic transaminase, glutamic oxaloacetic transaminase, fasting plasma glucose, uric acid, triglyceride, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol are closely associated with the risk for NAFLD. SBP (odds ratio [OR]: 1.092, 95% confidence interval [CI]: 1.030–1.158; P  < 0.05) and DBP (OR: 1.157, 95%CI: 1.094–1.223; P  < 0.05) were found to be independent risk factors for NAFLD. Our analysis indicates that BP is significantly associated with NAFLD in nonhypertensive individuals; SBP and DBP are found to be independent risk factors for NAFLD.
Author Tu, Jian-Fei
Ding, Ya-Hui
Huang, Dong-Sheng
Pang, Jie
Qian, Lin-Yan
Che, Xian-Da
Zou, Hai
AuthorAffiliation Department of Cardiology, Zhejiang Provincial People's Hospital, Hangzhou Department of Radiology and Interventional Radiology, Lishui Central Hospital, Lishui, Zhejiang Province Department of Hepatobiliary Surgery, Zhejiang Provincial People's Hospital, Hangzhou, China
AuthorAffiliation_xml – name: Department of Cardiology, Zhejiang Provincial People's Hospital, Hangzhou Department of Radiology and Interventional Radiology, Lishui Central Hospital, Lishui, Zhejiang Province Department of Hepatobiliary Surgery, Zhejiang Provincial People's Hospital, Hangzhou, China
– name: b Department of Radiology and Interventional Radiology, Lishui Central Hospital, Lishui, Zhejiang Province
– name: a Department of Cardiology, Zhejiang Provincial People's Hospital, Hangzhou
– name: c Department of Hepatobiliary Surgery, Zhejiang Provincial People's Hospital, Hangzhou, China
Author_xml – sequence: 1
  givenname: Lin-Yan
  surname: Qian
  fullname: Qian, Lin-Yan
  organization: Department of Cardiology, Zhejiang Provincial People's Hospital, Hangzhou Department of Radiology and Interventional Radiology, Lishui Central Hospital, Lishui, Zhejiang Province Department of Hepatobiliary Surgery, Zhejiang Provincial People's Hospital, Hangzhou, China
– sequence: 2
  givenname: Jian-Fei
  surname: Tu
  fullname: Tu, Jian-Fei
– sequence: 3
  givenname: Ya-Hui
  surname: Ding
  fullname: Ding, Ya-Hui
– sequence: 4
  givenname: Jie
  surname: Pang
  fullname: Pang, Jie
– sequence: 5
  givenname: Xian-Da
  surname: Che
  fullname: Che, Xian-Da
– sequence: 6
  givenname: Hai
  surname: Zou
  fullname: Zou, Hai
– sequence: 7
  givenname: Dong-Sheng
  surname: Huang
  fullname: Huang, Dong-Sheng
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27442673$$D View this record in MEDLINE/PubMed
BookMark eNp9kc1uEzEUhS1URNPCEyAhL9lM67-xMQukquWnUgsbWFuO5w5jcMaD7UmUB-C9cZIWlS7wxta93zlHvvcEHY1xBIReUnJGiVbnt1dn5MERTPMnaEFbLptWS3GEFoSwtlFaiWN0kvMPQihXTDxDx0wJwaTiC_T7IufovC0-jjj2eBli7PCUIOc5AQ6whoA3vgy4ptvg4hCDd7i3pWxx8GtIuPMZbAbsxx0zbCdIBcZce3iK0xz23m_x55hWNmCfK1VwGQCPsKnvXfU5etrbkOHF3X2Kvn14__XyU3Pz5eP15cVN4wRpecOd5ZwoqwWhnXa8J04oyQSjqqsDWHLBBTgtAVreS3AUlpqzCiumlJOUn6J3B99pXq6gczCWZIOZkl_ZtDXRevNvZ_SD-R7XpmWyVZpUg9d3Bin-miEXs_LZQQh2hDhnQ98QKbhmTFT01cOsvyH3s6-APgAuxZwT9Mb5sh9WjfbBUGJ2eza3V-bxnquWP9Le2_9fJQ6qTQwFUv4Z5g0kM4ANZdjj9ZOsYYRKoqgmzU7I-R9wCLwg
CitedBy_id crossref_primary_10_3390_nu12082435
crossref_primary_10_7759_cureus_34921
crossref_primary_10_1161_HYPERTENSIONAHA_119_13419
crossref_primary_10_3389_fcvm_2024_1338156
crossref_primary_10_1016_j_jhep_2017_09_021
crossref_primary_10_4103_ejim_ejim_95_18
crossref_primary_10_3390_jcdd9120419
crossref_primary_10_3390_microorganisms9112351
crossref_primary_10_3389_fendo_2022_942647
crossref_primary_10_1002_mnfr_202100356
crossref_primary_10_26693_jmbs06_05_239
crossref_primary_10_1080_07853890_2023_2195203
crossref_primary_10_1097_MEG_0000000000001191
crossref_primary_10_47743_jemb_2024_204
crossref_primary_10_1016_j_diabres_2022_109819
crossref_primary_10_1152_physiol_00013_2023
crossref_primary_10_1097_CD9_0000000000000113
crossref_primary_10_1155_2020_3580840
crossref_primary_10_18699_SSMJ20210510
crossref_primary_10_2147_DMSO_S396011
crossref_primary_10_26442_00403660_2022_02_201363
crossref_primary_10_7759_cureus_65089
crossref_primary_10_1186_s43066_024_00341_8
Cites_doi 10.1007/s11906-009-0026-5
10.1136/gut.2003.027086
10.1161/HYPERTENSIONAHA.111.175125
10.1080/08037050050151762
10.1001/jama.290.22.2945
10.1097/HJH.0b013e32833a7de6
10.1016/j.numecd.2012.05.007
10.3748/wjg.v22.i5.1884
10.1001/jama.290.22.3000
10.1016/S0002-9343(99)00271-5
10.1093/eurheartj/ehl254
10.1097/HJH.0b013e32830dfe4b
10.1097/MEG.0b013e32834b8d52
10.1007/s10620-011-1819-3
10.1016/j.jhep.2014.01.009
10.1161/01.RES.66.5.1400
10.1016/j.numecd.2009.11.015
10.1016/j.jhep.2008.11.021
10.2337/diabetes.50.8.1844
10.1001/jama.285.19.2486
10.1161/circ.106.25.3143
10.1371/journal.pone.0088569
10.1016/j.jhep.2008.05.003
10.2337/diabetes.54.11.3252
10.1038/nrgastro.2013.171
10.1161/CIRCULATIONAHA.105.169404
10.1016/j.jacc.2003.12.049
ContentType Journal Article
Copyright The Authors. Published by Wolters Kluwer Health, Inc. All rights reserved.
Copyright © 2016 the Author(s). Published by Wolters Kluwer Health, Inc. All rights reserved. 2016
Copyright_xml – notice: The Authors. Published by Wolters Kluwer Health, Inc. All rights reserved.
– notice: Copyright © 2016 the Author(s). Published by Wolters Kluwer Health, Inc. All rights reserved. 2016
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1097/MD.0000000000004293
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1536-5964
EndPage e4293
ExternalDocumentID PMC5265790
27442673
10_1097_MD_0000000000004293
00005792-201607190-00043
Genre Journal Article
GroupedDBID ---
.-D
.XZ
.Z2
01R
0R~
354
40H
4Q1
4Q2
4Q3
5GY
5RE
5VS
71W
77Y
7O~
AAAAV
AAGIX
AAHPQ
AAIQE
AAMOA
AAQKA
AARTV
AASCR
AAWTL
AAXQO
AAYEP
ABASU
ABBUW
ABCQX
ABDIG
ABFRF
ABOCM
ABVCZ
ABXVJ
ABZAD
ABZZY
ACDDN
ACEWG
ACGFO
ACGFS
ACILI
ACLDA
ACWDW
ACWRI
ACXJB
ACXNZ
ACZKN
ADGGA
ADHPY
ADNKB
ADPDF
AE6
AEFWE
AENEX
AFBFQ
AFDTB
AGOPY
AHOMT
AHQNM
AHVBC
AIJEX
AINUH
AJCLO
AJIOK
AJNWD
AJNYG
AJZMW
AKCTQ
AKULP
ALKUP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AOHHW
AOQMC
BQLVK
CS3
DIWNM
DU5
E.X
EBS
EEVPB
EJD
ERAAH
EX3
F2K
F2L
F2M
F2N
F5P
FCALG
FD6
FIJ
FL-
GNXGY
GQDEL
GROUPED_DOAJ
H0~
HLJTE
HYE
HZ~
H~9
IKREB
IKYAY
IN~
IPNFZ
JK3
JK8
K8S
KD2
KMI
KQ8
L-C
N9A
N~7
N~B
O9-
OAG
OAH
OB2
OHH
OK1
OL1
OLB
OLG
OLH
OLU
OLV
OLY
OLZ
OPUJH
OUVQU
OVD
OVDNE
OVEED
OVIDH
OVLEI
OWV
OWW
OWZ
OXXIT
P2P
RIG
RLZ
RPM
RXW
S4R
S4S
TAF
TEORI
TSPGW
UNMZH
V2I
VVN
W3M
WOQ
WOW
X3V
X3W
XYM
YFH
YOC
ZFV
ZY1
.3C
.55
.GJ
1CY
53G
AAYXX
ADFPA
ADGHP
AE3
AFFNX
AFUWQ
AHRYX
BS7
BYPQX
CITATION
FW0
JF9
JG8
N4W
N~M
OCUKA
ODA
ORVUJ
OWU
P-K
R58
T8P
X7M
XXN
ZGI
ZXP
ACIJW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ADKSD
ADSXY
5PM
ID FETCH-LOGICAL-c4053-3ca3307a9401d9c3f0c47624217d004b3434ec96ee53f6ec1eb9324017277c613
ISSN 0025-7974
IngestDate Thu Aug 21 18:15:59 EDT 2025
Mon Sep 08 12:27:29 EDT 2025
Thu Apr 03 07:09:04 EDT 2025
Tue Jul 01 01:21:31 EDT 2025
Thu Apr 24 22:53:22 EDT 2025
Fri May 16 04:11:57 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 29
Language English
License This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially. http://creativecommons.org/licenses/by-nc/4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c4053-3ca3307a9401d9c3f0c47624217d004b3434ec96ee53f6ec1eb9324017277c613
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink http://dx.doi.org/10.1097/MD.0000000000004293
PMID 27442673
PQID 1806439224
PQPubID 23479
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5265790
proquest_miscellaneous_1806439224
pubmed_primary_27442673
crossref_citationtrail_10_1097_MD_0000000000004293
crossref_primary_10_1097_MD_0000000000004293
wolterskluwer_health_00005792-201607190-00043
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2016-July-01
PublicationDateYYYYMMDD 2016-07-01
PublicationDate_xml – month: 07
  year: 2016
  text: 2016-July-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Medicine (Baltimore)
PublicationTitleAlternate Medicine (Baltimore)
PublicationYear 2016
Publisher The Authors. Published by Wolters Kluwer Health, Inc. All rights reserved
Wolters Kluwer Health
Publisher_xml – name: The Authors. Published by Wolters Kluwer Health, Inc. All rights reserved
– name: Wolters Kluwer Health
References Salvi (R3-43-20210309) 2010; 28
Fotbolcu (R27-43-20210309) 2010; 17
Bjorntorp (R7-43-20210309) 2000; 9
Grundy (R10-43-20210309) 2003; 290
Capasso (R26-43-20210309) 1990; 66
Sesso (R8-43-20210309) 2003; 290
Sesti (R17-43-20210309) 2014; 9
Li (R16-43-20210309) 2009; 50
Lu (R18-43-20210309) 2016; 22
Bombelli (R21-43-20210309) 2011; 58
Donati (R22-43-20210309) 2004; 53
Loomba (R1-43-20210309) 2013; 10
Sciacqua (R25-43-20210309) 2011; 21
Sung (R20-43-20210309) 2014; 60
Fallo (R15-43-20210309) 2008; 26
Lee (R24-43-20210309) 2012; 57
National Cholesterol Education Program Expert Panel on Detection (R4-43-20210309) 2002; 106
Bellentani (R28-43-20210309) 2008; 49
Laurent (R23-43-20210309) 2006; 27
Schillaci (R12-43-20210309) 2004; 43
Expert Panel on Detection (R9-43-20210309) 2001; 285
Reynolds (R11-43-20210309) 2009; 11
Marchesini (R19-43-20210309) 1999; 107
Grundy (R5-43-20210309) 2005; 112
Catena (R13-43-20210309) 2013; 23
Rutter (R6-43-20210309) 2005; 54
Lopez-Suarez (R14-43-20210309) 2011; 23
Marchesini (R2-43-20210309) 2001; 50
References_xml – volume: 11
  start-page: 150
  year: 2009
  ident: R11-43-20210309
  article-title: Update on the metabolic syndrome: hypertension
  publication-title: Curr Hypertens Rep
  doi: 10.1007/s11906-009-0026-5
– volume: 53
  start-page: 1020
  year: 2004
  ident: R22-43-20210309
  article-title: Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance
  publication-title: Gut
  doi: 10.1136/gut.2003.027086
– volume: 58
  start-page: 1029
  year: 2011
  ident: R21-43-20210309
  article-title: Impact of body mass index and waist circumference on the long-term risk of diabetes mellitus, hypertension, and cardiac organ damage
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.111.175125
– volume: 9
  start-page: 71
  year: 2000
  ident: R7-43-20210309
  article-title: Hypertension and the metabolic syndrome: closely related central origin?
  publication-title: Blood Press
  doi: 10.1080/08037050050151762
– volume: 290
  start-page: 2945
  year: 2003
  ident: R8-43-20210309
  article-title: C-reactive protein and the risk of developing hypertension
  publication-title: JAMA
  doi: 10.1001/jama.290.22.2945
– volume: 17
  start-page: 457
  year: 2010
  ident: R27-43-20210309
  article-title: Impairment of the left ventricular systolic and diastolic function in patients with non-alcoholic fatty liver disease
  publication-title: Cardiol J
– volume: 28
  start-page: 1699
  year: 2010
  ident: R3-43-20210309
  article-title: Increased arterial stiffness in nonalcoholic fatty liver disease: the Cardio-GOOSE study
  publication-title: J Hypertens
  doi: 10.1097/HJH.0b013e32833a7de6
– volume: 23
  start-page: 389
  year: 2013
  ident: R13-43-20210309
  article-title: Ambulatory arterial stiffness indices and non-alcoholic fatty liver disease in essential hypertension
  publication-title: Nutr Metab Cardiovasc Dis
  doi: 10.1016/j.numecd.2012.05.007
– volume: 22
  start-page: 1884
  year: 2016
  ident: R18-43-20210309
  article-title: Association between serum alpha-L-fucosidase and non-alcoholic fatty liver disease: cross-sectional study
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v22.i5.1884
– volume: 290
  start-page: 3000
  year: 2003
  ident: R10-43-20210309
  article-title: Inflammation, hypertension, and the metabolic syndrome
  publication-title: JAMA
  doi: 10.1001/jama.290.22.3000
– volume: 107
  start-page: 450
  year: 1999
  ident: R19-43-20210309
  article-title: Association of nonalcoholic fatty liver disease with insulin resistance
  publication-title: Am J Med
  doi: 10.1016/S0002-9343(99)00271-5
– volume: 27
  start-page: 2588
  year: 2006
  ident: R23-43-20210309
  article-title: Expert consensus document on arterial stiffness: methodological issues and clinical applications
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehl254
– volume: 26
  start-page: 2191
  year: 2008
  ident: R15-43-20210309
  article-title: Nonalcoholic fatty liver disease, adiponectin and insulin resistance in dipper and nondipper essential hypertensive patients
  publication-title: J Hypertens
  doi: 10.1097/HJH.0b013e32830dfe4b
– volume: 23
  start-page: 1011
  year: 2011
  ident: R14-43-20210309
  article-title: Nonalcoholic fatty liver disease is associated with blood pressure in hypertensive and nonhypertensive individuals from the general population with normal levels of alanine aminotransferase
  publication-title: Eur J Gastroenterol Hepatol
  doi: 10.1097/MEG.0b013e32834b8d52
– volume: 57
  start-page: 196
  year: 2012
  ident: R24-43-20210309
  article-title: The relationship between arterial stiffness and nonalcoholic fatty liver disease
  publication-title: Digest Dis Sci
  doi: 10.1007/s10620-011-1819-3
– volume: 60
  start-page: 1040
  year: 2014
  ident: R20-43-20210309
  article-title: Development of new fatty liver, or resolution of existing fatty liver, over five years of follow-up, and risk of incident hypertension
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2014.01.009
– volume: 66
  start-page: 1400
  year: 1990
  ident: R26-43-20210309
  article-title: Left ventricular failure induced by long-term hypertension in rats
  publication-title: Circ Res
  doi: 10.1161/01.RES.66.5.1400
– volume: 21
  start-page: 485
  year: 2011
  ident: R25-43-20210309
  article-title: Endothelial dysfunction and non-alcoholic liver steatosis in hypertensive patients
  publication-title: Nutr Metab Cardiovasc Dis
  doi: 10.1016/j.numecd.2009.11.015
– volume: 50
  start-page: 1029
  year: 2009
  ident: R16-43-20210309
  article-title: Association of serum uric acid level with non-alcoholic fatty liver disease: a cross-sectional study
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2008.11.021
– volume: 50
  start-page: 1844
  year: 2001
  ident: R2-43-20210309
  article-title: Nonalcoholic fatty liver disease: a feature of the metabolic syndrome
  publication-title: Diabetes
  doi: 10.2337/diabetes.50.8.1844
– volume: 285
  start-page: 2486
  year: 2001
  ident: R9-43-20210309
  article-title: Treatment of High Blood Cholesterol in A. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).
  publication-title: JAMA
  doi: 10.1001/jama.285.19.2486
– volume: 106
  start-page: 3143
  year: 2002
  ident: R4-43-20210309
  article-title: Treatment of High Blood Cholesterol in A. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.
  publication-title: Circulation
  doi: 10.1161/circ.106.25.3143
– volume: 9
  start-page: e88569
  year: 2014
  ident: R17-43-20210309
  article-title: Association between noninvasive fibrosis markers and chronic kidney disease among adults with nonalcoholic fatty liver disease
  publication-title: PloS One
  doi: 10.1371/journal.pone.0088569
– volume: 49
  start-page: 300
  year: 2008
  ident: R28-43-20210309
  article-title: Liver and heart: a new link?
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2008.05.003
– volume: 54
  start-page: 3252
  year: 2005
  ident: R6-43-20210309
  article-title: Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study
  publication-title: Diabetes
  doi: 10.2337/diabetes.54.11.3252
– volume: 10
  start-page: 686
  year: 2013
  ident: R1-43-20210309
  article-title: The global NAFLD epidemic
  publication-title: Nat Rev Gastroenterol Hepatol
  doi: 10.1038/nrgastro.2013.171
– volume: 112
  start-page: 2735
  year: 2005
  ident: R5-43-20210309
  article-title: Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.105.169404
– volume: 43
  start-page: 1817
  year: 2004
  ident: R12-43-20210309
  article-title: Prognostic value of the metabolic syndrome in essential hypertension
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2003.12.049
SSID ssj0013724
Score 2.305589
Snippet The functional crosstalk between nonalcoholic fatty liver disease (NAFLD) and hypertension has been reported by some literatures; however, in nonhypertensive...
SourceID pubmedcentral
proquest
pubmed
crossref
wolterskluwer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage e4293
SubjectTerms Adult
Blood Pressure
Cross-Sectional Studies
Female
Humans
Hypertension - blood
Liver Function Tests
Male
Metabolic Syndrome - blood
Middle Aged
Non-alcoholic Fatty Liver Disease - diagnosis
Observational Study
Reference Values
Statistics as Topic
Title Association of blood pressure level with nonalcoholic fatty liver disease in nonhypertensive population: Normal is not the new normal
URI https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00005792-201607190-00043
https://www.ncbi.nlm.nih.gov/pubmed/27442673
https://www.proquest.com/docview/1806439224
https://pubmed.ncbi.nlm.nih.gov/PMC5265790
Volume 95
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ta9swEBZZC2Mwxt6Xbisa7FumzpYUO_q4NSmhkK2DdLSfjF-U1ix1Qpsw2H_Yf96dXhwnKWNrPphgy2-6x6eT7u45Qt6LQuiikD0WRVwzmQWSqUxwplQWcRUjxxfmDo--RMNTeXzWPWu1fjeilpaL7CD_dWteyV2kCvtArpgl-x-SrS8KO-A_yBe2IGHY_pOMG32LRp8JQu-YyFZ0C0wxHsgutFZob5tauGXemaQLLBeBARneP4OrHtDmEial1z6kfV6X9moasCPni0fL9HM6XZQ2ULdeTvhWumSGsmLnK-SNlwYucJAd6bK2nl1BlfOUDZf13hO3hH1c6uaaRBjV8atO883Q03_TcZH-NqGqqYWxhK6y1XkOtFe8Eesqy2juNbMtv-kQaN9kS-NbJuFR3xJRuh8MsqLZGsQ2vzIgQEJEHtnqKRtE2yejQ6wVEKvgHtnlcYxe_92v3weD_sotFXNZ1wCGF_A0Vir-eMsTING0u9261bM1ldmOyH340_bhD9OFDZNn_Jg8cnMV-skC7wlp6eopue8R8IxcNPBHZxNq8Ec9_qjBH0X80Sb-qMEfNfijDn-0rOgG_ugKf8_J6dFgfDhkrnAHy8H-F0zkqYCxI1UweS9ULiZBLmNMRArjAromE1JInatI666YRDoPdaaQGBKN6TgHA_MF2YGb6leEBjpIpeKpiLpKwtxWFb0A1I6SKsxgsOVtwn3HJrljtcfiKtPER1eM-smmYNrkQ33S3JK6_L35Oy-xBJQvetTSSs-WN0nYMxY9mMFt8tJKsL6gF32bxGuyrRsgsfv6kaq8NATvDoZtwtZQkNjUaPN8cJwzbukhleWGEHt3vtNr8mD1Gb8hO4vrpX4LxvYi2zeLVPvuQ_gDiyLRzA
linkProvider Ovid
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1tj5NAEN5oL1ETY3y3vq6J4ZMoZRe2a9IPTctZzwNN2tPzE4FlyTU2tGmpxh_g_3Zm2eLViybyBQIDIcywPMs88wwhL1jBdFHwvhuGvnZ57nFX5sx3pcxDXwrU-MLa4TgJJyf86DQ4tWwLrIXB6rPN6hWuzDiNG9gPByeGs8HR1Emiz9NB5Yymo8EX5-PwbWT-UyNLwhkPlt_K2hkmhn8VCOlDDBgBNdlUT7PL5CAMAAJ0yMGHT1E0_p1vED5vm7sCxN7pE0nxOh43God2gfGb7X_DLgDTi_zK69-XmPvefDXU93MfsMOb5IZFnnTYhMotcklXt8mV2ObW75Cf5zxFlyU1lHZqeLLbtaYLZBdR_G1LK0TvprPuXNEyq-sfdIH0DmqzPXReoc0ZTHHXliBPV22jsDc0QZy8oPMNWNUUECgFbA_buPcuOTmMZqOJa5s0uAqwHnOZyhiME5mEiVohFSs9xQUWnfREAU8rZ5xxrWSodcDKUKueziWKACJwEgrAxD3SgVvSDwj1tJdx6WcsDCSHeYws-h6EmOSyl8PA6neJv3vsqbIK5thIY5HuMunxOP3TV13ysj1p1Qh4_Nv8-c6fKbxomD3JKr3cbtJe36A3gDxdcr_xb3tBlFn0QwFniz3PtwYo4r1_pJqfGTFvbE8gpNcl7l6MpE0ZbPq3SH74n_bPyNXJLD5Oj98l7x-Ra3i0IR0_Jp16vdVPAFrV-VP7XvwC0roXwg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3bbtNAEB2VVKqQEKJcw6UsEvITRo53Y3uR_FDFDqUQt1JaKE-WL2s1InKixAH1A_hvZtYXGoqQyEss79iyPLuzZz1nzwC85jlXeS4803FsZYrUEqZMuW1KmTq2dEnji_YOTyLn6FwcXwwvdqDNmNLms_XyLf3pME0HVA6H1oVn_vHUGE1H_lcjCr9M_cg4PXwf6s_URJIwToOxf2UE_uJ7URnBid_qM06CWqSw-WEA5rdg1_Nw6u3B7snnMAx-5x1cW3RFXhFqtzpFf7_N9lx2A6De5Fne-bGgHPj6m6bAX5vIxvfgboNA2WHdZfZhR5X3YW_S5NgfwM9rHmOLgmlqO9N82c1KsTmxjBh9vmUloXhdYXeWsSKpqis2J5oHa7I-bFaSzSUudVcNUZ4tu4Jh71hEeHnOZmu0qhgiUYYYH4_p7EM4H4dnoyOzKdZgZoj5uMmzhGO8SCQu2HKZ8cLKhEubTwZujm8r5YILlUlHqSEvHJUNVCpJDJAAlJshqHgEPXwk9QSYpaxESDvhzlAKXM_I3LOwq0khBykGWLsPdvva46xRMqeCGvO4zahPgvhPX_XhTXfRshby-Lf5q9afMQ44yqIkpVps1vHA0ygOoU8fHtf-7W5Icou24-LV7pbnOwMS895uKWeXWtSbyhS40uqDudVH4no7rH4-bLcxqmlJQFnrAfCn_2n_EvZwnMSfPkQfn8Ftaqy5x8-hV6026gUirCo9aIbFLxNQGU0
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+of+blood+pressure+level+with+nonalcoholic+fatty+liver+disease+in+nonhypertensive+population&rft.jtitle=Medicine+%28Baltimore%29&rft.au=Qian%2C+Lin-Yan&rft.au=Tu%2C+Jian-Fei&rft.au=Ding%2C+Ya-Hui&rft.au=Pang%2C+Jie&rft.date=2016-07-01&rft.pub=Wolters+Kluwer+Health&rft.issn=0025-7974&rft.eissn=1536-5964&rft.volume=95&rft.issue=29&rft_id=info:doi/10.1097%2FMD.0000000000004293&rft_id=info%3Apmid%2F27442673&rft.externalDocID=PMC5265790
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0025-7974&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0025-7974&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0025-7974&client=summon